+44 1300 500008Journal of Antivirals & Antiretrovirals : Citations & Metrics Report
Articles published in Journal of Antivirals & Antiretrovirals have been cited by esteemed scholars and scientists all around the world. Journal of Antivirals & Antiretrovirals has got h-index 22, which means every article in Journal of Antivirals & Antiretrovirals has got 22 average citations.
Following are the list of articles that have cited the articles published in Journal of Antivirals & Antiretrovirals.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
59 | 57 | 32 | 59 | 77 | 13 | 11 | 20 | 37 | 22 | 37 | 55 | 22 | 12 |
Research, Review articles and Editorials |
1 | 0 | 5 | 42 | 32 | 12 | 10 | 14 | 27 | 21 | 33 | 44 | 21 | 10 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
48 | 57 | 27 | 17 | 45 | 1 | 1 | 6 | 10 | 1 | 4 | 11 | 1 | 2 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 35 | 51 | 125 | 100 | 191 | 0 | 125 | 177 |
Citations received as per Google Scholar, other indexing platforms and portals |
98 | 160 | 172 | 269 | 223 | 172 | 219 | 195 | 170 | 116 | 60 | 36 | 26 | 58 |
| Journal total citations count | 2004 |
| Journal impact factor | 5.32 |
| Journal 5 years impact factor | 5.62 |
| Journal cite score | 5.3 |
| Journal h-index | 22 |
| Journal h-index since 2019 | 17 |
Important citations (1101)
Ytic bacteriophages and phage cocktails seem to be a future alternative against multi-drug resistant bacterial infections |
|
Bacteriophage treatment: critical evaluation of its application on world health organization priority pathogens |
|
A study of therapeutic potential of staphylococcus aureus bacteriophage in treating methicillin resistant |
|
Application of the resazurin cell viability assay to monitor escherichia coli and salmonella typhimurium inactivation mediated by phages |
|
Bacteriophage treatment: critical evaluation of its application on world health organization priority pathogens |
|
A single dose of a virulent bacteriophage vb paep-sapl, rescues bacteremic mice infected with multi drug resistant pseudomonas aeruginosa |
|
Analysis of susceptibility patterns of pseudomonas aeruginosa and isolation, characterization of lytic bacteriophages targeting multi drug resistant pseudomonas aeruginosa |
|
Efficacy of bacteriophage against multidrug resistant pseudomonas aeruginosa isolates |
|
A need for careful consideration of bacteriophage therapy |
|
Nanomedicine and advanced technologies for burns: preventing infection and facilitating wound healing |
|
Safety and tolerability of bacteriophage therapy for chronic rhinosinusitis due to staphylococcus aureus |
|
Phage ?pan70, a putative temperate phage, controls pseudomonas aeruginosa in planktonic, biofilm and burn mouse model assays |
|
How phages overcome the challenges of drug resistant bacteria in clinical infections |
|
Isolation and characterization of bacteriophage to control multidrug-resistant pseudomonas aeruginosa planktonic cells and biofilm |
|
Efficiency of single phage suspensions and phage cocktail in the inactivation of escherichia coli and salmonella typhimurium: an in vitro preliminary study |
|
Naïve t cells in immunosuppression diseases: human immunodeficiency virus and cytomegalovirus |
|
Indian medicinal plants and formulations and their potential against covid-19–preclinical and clinical research |
|
The genus jatropha (euphorbiaceae): a review on secondary chemical metabolites and biological aspects |
|
An overview of anti-diabetic plants used in gabon: pharmacology and toxicology |
|
Assessment of antioxidant and cytoprotective potential of jatropha (jatropha curcas) grown in southern italy |
|